Latin America Next Generation Sequencing Market

1. Latin America Next Generation Sequencing Market Growth, Top Keyplayers | Meticulous Market Research Pvt. Ltd. Latin America Next Generation Sequencing market is predicted to develop at a CAGR of 14.3% from 2020 to 2027 to attain $714.8 million by way of 2027. Next generation sequencing is a technology used to determine the series of DNA or RNA to have a look at genetic variant related to illnesses. the velocity, throughput, and accuracy of NGS has revolutionized genetic evaluation and enabled its use in new applications in genomic and medical research; reproductive health; and environmental, agricultural, and forensic science. The growth on this marketplace is majorly driven through the technological advancements in sequencing tactics, surge in genome mapping applications, and increase in drug discovery platforms worrying NGS technology. further, the boom in personalised medicine studies, growing authorities initiatives for large-scale genomic sequencing initiatives, and emergence of cloud computing as a capacity information control provider helps the growth of the Latin the us NGS market. Growth of the global next generation sequencing market is majorly driven by using growth in genome mapping programs; rise in applications of next generation sequencing; boom in healthcare expenditure; and technological advancements in sequencing systems. for example, in 2019, Thermo Fisher medical, a world leader in serving science, launched Ion Torrent Genexus machine that is a subsequent technology platform that supply the specimen to document in only a single day. moreover, in 2019, Agilent technologies, Inc., an American analytical development and manufacturing enterprise, released Magnis NGS Prep device, a next generation sequencing library preparation device that's designed to run the complex sequencing assays in a press of a button. The genetic make- up and configuration of the fetus can be detected through NGS-orientated checks consisting of non- invasive prenatal trying out (NIPT), and pre-implantation genetic checking out (PGT). The R&D related to NGS has been escalating to new heights via more investment in NGS technology for the duration of the arena. Surge in demand for genome mapping application and rise in software of NGS boosts the growth of the market. Based on type, the consumable segment is estimated to account for the largest share of the Latin the us NGS market in 2020. The large share of this segment is specially attributed to the frequent use of consumables during sequencing procedures. Based on sequencing type, the targeted sequencing segment is expected to account for the largest share of the Latin the usa NGS market in 2020. The fundamental share of this phase is in general due to the better adoption of targeted sequencing with capability of the technique to call editions at lower costs in comparison to different sequencing technologies, and ability to generate manageable facts volumes with reliable results. Based on technology, the sequencing by using synthesis segment is anticipated to command the main share of the Latin america next-generation sequencing market in 2020 and is likewise slated to develop on the quickest CAGR at some stage in the forecast period. The large proportion of this section is attributed to the high accuracy of SBS generation in DNA sequencing, maximum yield of mistakes unfastened throughput, and growing incorporation of this era in NGS instrumentation. Based totally on end user, the scientific diagnostic laboratories phase is expected to account for the largest share of this marketplace in 2020. The big percentage of this phase is in particular because of the rising pool of most cancers sufferers visiting diagnostic laboratories and developing investments in those centers within the region. This research report analyzes major countries and provides comprehensive analysis for countries like Brazil, Mexico, Argentina, Chile, and rest of Latin america. Brazil is anticipated to command the largest

2. share of the Latin america NGS marketplace in 2020. The increase in this market is predicted to be driven by way of the elements including growing burden of genetic disorders including cancer in the region, growing investments in personalized medicinal drug improvement, and developing investments by way of the predominant players on this region. The key players operating in the Latin america NGS market are Illumina, Inc. (U.S.), Thermo Fisher scientific Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Qiagen N.V. (Netherlands), Oxford Nanopore technologies Ltd (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), PerkinElmer, Inc. (U.S.), F. Hoffmann-la Roche AG (Switzerland), and 10x Genomics, Inc. (U.S.) among others. Key questions answered in the report Key questions answered in the report- - • which are the high growth market segments in terms of factor, application, vertical, organization size, and international locations? • What was the historic market for hyper-converged infrastructure systems marketplace (HCI) across the globe? • What are the market forecasts and estimates for the period 2021-2028? • What are the principal drivers, restraints, opportunities, and developments within the hyper- converged infrastructure systems market? • who're the predominant players and their share within the hyper-converged infrastructure systems market? • How is the competitive landscape in the hyper-converged infrastructure structures market? • What are the current traits within the hyper-converged infrastructure structures market? • What are the exclusive strategies adopted by using the principal players in the hyper-converged infrastructure systems market? • What are the key geographic trends, and that are the high-growth countries? Contact: Contact: Mr. Khushal Bombe Meticulous market research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. U.s.a.: +1–646–781–8004 Europe : +44–203–868–8738 APAC: +91 744–7780008 Email- sales@meticulousresearch.com